a drug company
Industry Biotechnology
A.I.dvisor tells us that CRIS and INKT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRIS and INKT's prices will move in lockstep.
Ticker / NAME | Correlation To CRIS | 1D Price Change % | ||
---|---|---|---|---|
CRIS | 100% | -4.80% | ||
INKT - CRIS | 29% Poorly correlated | +1.22% | ||
XENE - CRIS | 28% Poorly correlated | -0.47% | ||
CDIO - CRIS | 25% Poorly correlated | -12.00% | ||
PULM - CRIS | 23% Poorly correlated | +0.24% | ||
CTXR - CRIS | 23% Poorly correlated | -4.02% | ||
More |
Ticker / NAME | Correlation To CRIS | 1D Price Change % |
---|---|---|
CRIS | 100% | -4.80% |
drugs theme (265 stocks) | 17% Poorly correlated | +5.37% |
biotechnology theme (248 stocks) | 13% Poorly correlated | +5.56% |